Scandinavian Journal of Rheumatology

The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review
pp. 411-417(7)
Authors: Kristensen, L. E.; Christensen, R.; Bliddal, H.; Geborek, P.; Danneskiold-Samsøe, B.; Saxne, T.

Infliximab dosage and infusion frequency in clinical practice: experiences in the Stockholm biologics registry STURE
pp. 418-423(6)
Authors: van Vollenhoven, R. F.; Klareskog, L.

Intensifying treatment of rheumatoid arthritis with combinations of traditional disease-modifying anti-rheumatic drugs among patients with persistent disease did not reduce the need for large joint surgery
pp. 424-427(4)
Authors: Kononoff, A.; Heiskanen, J.; Lumiaho, J.; Kautiainen, H.; Kaipiainen-Seppänen, O.

Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis
pp. 428-433(6)
Authors: Jiao, Z.; Wang, W.; Jia, R.; Li, J.; You, H.; Chen, L.; Wang, Y.

The effect of endostatin evaluated in an experimental animal model of collagen-induced arthritis
pp. 434-441(8)
Authors: Kurosaka, D.; Yoshida, K.; Yasuda, J.; Yasuda, C.; Noda, K.; Furuya, K.; Ukichi, T.; Kingetsu, I.; Joh, K.; Yamaguchi, N.; Saito, S.; Yamada, A.

Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations
pp. 442-447(6)
Authors: Magalhães, M. B.; da Silva, L. M.; Voltarelli, J. C.; Donadi, E. A.; Louzada-Junior, P.

Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms
pp. 448-451(4)
Authors: Dinser, R.; Braun, A.; Jendro, M. C.; Engel, A.

Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience
pp. 452-457(6)
Authors: Wildt, M.; Hesselstrand, R.; Åkesson, A.; Scheja, A.

Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement
pp. 458-461(4)
Authors: de Oliveira, N. C.; Sabbag, L. M. dos Santos; Ueno, L. M.; de Souza, R. B. C.; Borges, C. L.; Pinto, A. L. de Sá; Lima, F. R.

Relapsing polychondritis in North India: a report of 10 patients
pp. 462-465(4)
Authors: Sharma, A.; Bambery, P.; Wanchu, A.; Sharma, Y. P.; Panda, N. K.; Gupta, A.; Singh, S.

Relative bone mineral density measured by metacarpal index (MCI) and chronic spinal syndromes: an epidemiological study
pp. 466-469(4)
Authors: Haara, M. M.; Arokoski, J. P. A.; Kröger, H.; Kärkkäinen, A.; Manninen, P.; Knekt, P.; Impivaara, O.; Heliövaara, M.

Urinary markers of altered collagen metabolism in fibromyalgia patients
pp. 470-477(8)
Authors: Ribel-Madsen, S.; Christgau, S.; Gronemann, S. T.; Bartels, E. M.; Danneskiold-Samsøe, B.; Bliddal, H.

Erythroleukaemia complicating ANA-negative systemic lupus erythematosus
pp. 478-480(3)
Authors: Eilertsen, G. Ø; Nossent, J. C.

Spurious thyroid function tests in systemic lupus erythematosus
pp. 480-482(3)
Authors: Massasso, D.; Joshua, F.

Antiphospholipid antibodies in children with Henoch-Schonlein purpura: a prospective study from North India
pp. 482-484(3)
Authors: Salhan, M.; Ahluwalia, J.; Singh, S.; Minz, R. W.

Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma
pp. 484-486(3)
Authors: Liozon, E.; Ouattara, B.; Loustaud-Ratti, V.; Vidal, E.

A case of recurrent abdominal bleeding due to polyarteritis nodosa despite immunosuppressive therapy
pp. 486-488(3)
Authors: Siebig, S.; Tarne, I. H.; Wrede, C. E.; Schölmerich, J.; Müller-Ladner, U.; Fleck, M.

Influence of acute physical activity immediately before ultrasonographic measurement of Achilles tendon thickness
pp. 488-489(2)
Authors: Fredberg, U.; Bolvig, L.; Lauridsen, A.; Stengaard-Pedersen, K.